info@marketresearchfuture.com   đź“ž  +1 (855) 661-4441(US)   đź“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Sleep Aids Market Research Report Information By Product (Mattresses & Pillows, Medications, Sleep Apnea Devices, and Others), By Sleep-Disorder (Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking, and Other Sleep Disorders), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032


ID: MRFR/HC/10218-HCR | 128 Pages | Author: Kinjoll Dey| November 2024

Sleep Aids Market Segmentation


Sleep Aids Product Outlook (USD Billion, 2018-2032)




  • Mattresses & Pillows




  • Medications




  • Sleep Apnea Devices




  • Others




Sleep Aids Sleep-Disorder Outlook (USD Billion, 2018-2032)




  • Insomnia




  • Sleep Apnea




  • Restless Legs Syndrome




  • Narcolepsy




  • Sleep Walking




  • Other Sleep Disorders




Sleep Aids Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • US Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • Canada Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders








  • Europe Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • Germany Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • France Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • UK Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • Italy Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • Spain Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • China Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • Japan Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • India Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • Australia Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • Middle East Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • Africa Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders






    • Latin America Outlook (USD Billion, 2018-2032)




    • Sleep Aids by Product




      • Mattresses & Pillows




      • Medications




      • Sleep Apnea Devices




      • Others






    • Sleep Aids by Sleep-Disorder




      • Insomnia




      • Sleep Apnea




      • Restless Legs Syndrome




      • Narcolepsy




      • Sleep Walking




      • Other Sleep Disorders








 


 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 Table of Contents

1. Executive summary

2. Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. Research Methodology

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. Market Dynamics

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. Market Factor Analysis

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL Sleep Aids MARKET, BY Product

6.1. Overview

6.2. Mattresses & Pillows

6.3. Medications

6.4. Sleep Apnea Devices

6.5. Others

7. GLOBAL Sleep Aids MARKET, BY Sleep-Disorder

7.1. Overview

7.2. Insomnia

7.3. Sleep Apnea

7.4. Restless Legs Syndrome

7.5. Narcolepsy

7.6. Sleep Walking

7.7. Other Sleep Disorders

8. GLOBAL Sleep Aids MARKET, by Region

1.1. Overview

1.2. North America

8.1.1. U.S.

8.1.2. Canada

8.2. Europe

8.2.1. Germany

8.2.2. France

8.2.3. U.K

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia-Pacific

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. Australia

8.3.6. Rest of Asia-Pacific

8.4. Rest of the World

8.4.1. Middle East

8.4.2. Africa

8.4.3. Latin America

9. Competitive Landscape

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Sleep Aids Market,

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Sleep Aids Market,

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch/Sleep-Disorder Deployment

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2022

9.8.2. Major Players R&D Expenditure. 2022

10. Company ProfileS

10.1. Acelity L.P. Inc.

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Products Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. ASTRAZENECA PLC

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Products Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Biodiem

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Products Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Cadwell Industries Inc.

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Products Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. COMPUMEDICS LIMITED

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Products Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. CSL Limited

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Products Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Drive

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Products Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Drive DeVilbiss Healthcare Inc.

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Products Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Eisai Co., Ltd.

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Products Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

11. Appendix

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 Global Sleep Aids Market, Synopsis, 2018-2032

TABLE 2 Global Sleep Aids Market, Estimates & Forecast, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 5 North America Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 6 North America Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 7 North America Sleep Aids MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 8 U.S. Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 9 U.S. Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 10 Canada Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 11 Canada Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 12 Europe Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 13 Europe Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 14 Europe Sleep Aids MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 15 Germany Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 16 Germany Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 17 France Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 18 France Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 19 Italy Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 20 Italy Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 21 Spain Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 22 Spain Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 23 U.K Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 24 U.K Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 25 Rest of Europe Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 26 Rest of Europe Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 27 Asia Pacific Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 28 Asia Pacific Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 29 Asia Pacific Sleep Aids MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 30 Japan Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 31 Japan Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 32 China Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 33 China Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 34 India Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 35 India Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 36 Australia Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 37 Australia Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 38 south korea Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 39 south korea Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 40 Rest of asia-pacific Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 41 Rest of asia-pacific Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 42 Rest of WOrld Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 43 Rest of WOrld Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 44 Rest of WOrld Sleep Aids MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 45 Middle east Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 46 Middle east Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 47 Africa Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 48 Africa Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

TABLE 49 Latin america Sleep Aids MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 50 Latin america Sleep Aids MARKET, BY SLEEP-DISORDER, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 Research Process

FIGURE 2 Market Structure for the Global Sleep Aids Market

FIGURE 3 Market Dynamics for the Global Sleep Aids Market

FIGURE 4 Global Sleep Aids Market, Share (%), BY Product, 2022

FIGURE 5 Global Sleep Aids Market, Share (%), BY SLEEP-DISORDER, 2022

FIGURE 6 Global Sleep Aids Market, Share (%), by Region, 2022

FIGURE 7 north AMERICA: Sleep Aids MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 Europe: Sleep Aids MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 Asia-Pacific: Sleep Aids MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 Rest of the world: Sleep Aids MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 Global Sleep Aids Market: Company Share Analysis, 2022 (%)

FIGURE 12 Acelity L.P. Inc.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 Acelity L.P. Inc.: SWOT ANALYSIS

FIGURE 14 ASTRAZENECA PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 ASTRAZENECA PLC: SWOT ANALYSIS

FIGURE 16 Biodiem: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 Biodiem: SWOT ANALYSIS

FIGURE 18 Cadwell Industries Inc.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 Cadwell Industries Inc.: SWOT ANALYSIS

FIGURE 20 COMPUMEDICS LIMITED.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 COMPUMEDICS LIMITED.: SWOT ANALYSIS

FIGURE 22 CSL Limited: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 CSL Limited: SWOT ANALYSIS

FIGURE 24 Drive: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 Drive: SWOT ANALYSIS

FIGURE 26 Drive DeVilbiss Healthcare Inc.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 Drive DeVilbiss Healthcare Inc.: SWOT ANALYSIS

FIGURE 28 Eisai Co., Ltd.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 Eisai Co., Ltd.: SWOT ANALYSIS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.